Using insights into Pim1 structure to design new anticancer drugs

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Human Pim1 kinase is a serine-threonine kinase involved in cell survival and proliferation.
• Pim1 overexpression is linked to human cancers, particularly hematopoietic malignancies and prostate carcinoma, indicating its proto-oncogenic role.
• Pim1 is an emerging target for drug discovery due to its association with poor prognosis in certain cancers.

Purpose of the Study:

• To summarize Pim1 functions and its role in human cancer.
• To analyze the three-dimensional structure of Pim1 and its complexes with small molecule inhibitors.
• To discuss molecular modeling techniques for identifying and optimizing selective Pim1 inhibitors.

Main Methods:

• Detailed inspection of available crystallographic data for Pim1.
• Analysis of literature data on Pim1 small molecule inhibitor complexes.
• Extensive discussion of molecular modeling techniques for inhibitor identification and optimization.

Main Results:

• Pim1 is a proto-oncogene implicated in cancer development and progression.
• The 3D structure of Pim1 and its inhibitor complexes have been analyzed.
• Molecular modeling offers a viable strategy for developing selective Pim1 inhibitors.

Conclusions:

• Selective inhibition of Pim1, distinct from Pim2 and Pim3, is crucial for therapeutic potential and understanding enzyme roles.
• Structural analysis and molecular modeling are valuable tools for medicinal chemists in developing small molecule kinase inhibitors.
• This review provides a detailed data collection on Pim1 structure and inhibitors, aiding future drug discovery efforts.